Product Information
ALPRAZOLAM XR 3 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.3214 per EA under NDC 59762006801. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
3 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762006801
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ALPRAZOLAMApproval Type
Authorized Generic (NDA)
FDA Application
NDA021434On Market Since
1/17/2003
Pharmacological Classes
Price Statistics
The NADAC for ALPRAZOLAM XR 3 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 45.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3214 per EA |
|---|---|
| All-time high | $0.9784 (Aug 10, 2016) |
| All-time low | $0.1851 (Jan 22, 2025) |
| 52-week high | $0.3886 |
| 52-week low | $0.2639 |
| Median price | $0.3543 |
| Average price | $0.4444 |
| Largest weekly change | +58.7% (May 17, 2023) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the alprazolam market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ALPRAZOLAM XR 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALPRAZOLAM XR 3 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.3214 per EA (NDC 59762006801), effective Jun 24, 2026.
How has the price of ALPRAZOLAM XR 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALPRAZOLAM XR 3 MG TABLET has declined 45.1%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ALPRAZOLAM XR 3 MG TABLET?
Since Nov 28, 2013, the NADAC for ALPRAZOLAM XR 3 MG TABLET has ranged from a low of $0.1851 (Jan 22, 2025) to a high of $0.9784 (Aug 10, 2016), with a median of $0.3543 per EA.
Are there cheaper alternatives to ALPRAZOLAM XR 3 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ALPRAZOLAM XR 3 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ALPRAZOLAM XR 3 MG TABLET?
ALPRAZOLAM XR 3 MG TABLET (NDC 59762006801) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification